Kalkine has a fully transformed New Avatar.

small-cap

Needle on One Penny Stock - OLI

Nov 07, 2019 | Team Kalkine
Needle on One Penny Stock - OLI


 

OLI Details
 

Oliver’s Real Food Limited

 
Reported EBITDA of $466k in Q1FY20: Oliver’s Real Food Limited (ASX: OLI) operates in the management of Quick Service Restaurants (“QSR”) in Australia under the branding of “Oliver’s Real Food.” The company specializes in fast food alternatives for travellers on Australia’s major arterial highways. As per a recent announcement, the company updated that the 2019 AGM will be held on 29 November 2019. The stock was suspended from Official Quotation in accordance with Listing Rule 17.5, from the commencement of trading on 01 October 2019, due to the failure to lodge the relevant periodic report within the due date. In a recent announcement, the company updated that the securities will be reinstated to official quotation from 06 November 2019, following the lodgement of FY19 Annual Report.
 
FY19 Financial Highlights for the period ending 30 June 2019: OLI declared its full year financial results wherein the company reported revenue at $34.97 million as compared to $35.94 million in FY18. The company reported net loss of $15.66 million as compared to a loss of $0.64 million in previous financial year. Loss during the period was largely due to impairments and write-offs. During FY19, the company reported EBITDA loss of $7.8 million as compared to a loss of $2.7 million in prior corresponding period. During the year, the company identified and closed a number of under-performing stores. At the end of the year, the company reported 25 owned stores across Australia. The company reported total current assets of $3.396 million including trade receivables and inventories at $0.61 million and $1.64 million, respectively. OLI’s plant property and equipment at the end of 30 June 2019 stood at $10.32 million.
 
Q1FY20 Financial Update for the Period ended 30 September 2019: OLI declared its first three months cash-flow statement wherein the company reported $0.221 million used in operating activities, $0.064 million derived from investing activities. OLI reported $0.42 million as net cash from financing activities. at the end of 30 September 2019, the company had a cash balance of $1.154 million. The company also reported a positive EBITDA of $466k for the first quarter of financial year 2020.


Q1FY20 Cash Flow Statement (Source: Company Reports)

Cash Flow Forecast: During the second quarter of FY20, OLI forecasted total cash outflow of $9.43 million, which includes $4.9 million for product manufacturing and operating costs, $3.85 million in staff costs, advertisement and marketing costs amounting to $0.18 million, and administration and corporate costs of $0.5 million.

Stock Recommendation: The stock of OLI is trading at $0.043 with outstanding shares amounting to 250.73 million. The stock has given returns of -2.22% and 46.67% during the last three-months and six-months, respectively. 52-week trading range of the stock stood at $0.019 to $0.120 and currently, the stock is trading close to the lower end of its 52-week trading range. In FY19, the company reported a net loss, largely due to the impairments and write-offs. The company also updated that July 2019 proved to be a positive month that continued through to the end of Q1FY20, reporting a positive EBITDA, aided by strong trading and tight management controls by the company. In FY19, the company had a gross margin of 73.5%, which is higher than the industry median of 51.8%. Considering the aforesaid facts, business prospects and recent price movements, we recommend a "Speculative Buy" rating on the stock at current market price of $0.043, down 2.273% as on 06 November 2019.


 
OLI Daily Technical Chart (Source: Thomson Reuters)


Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.